Aluminium-complexed alginate nanoparticles as an adjuvant for therapeutic vaccines against melanoma
RSC Pharmaceutics · 2025 · 2 (6) · 1593-1602
DOI: 10.1039/d5pm00111k ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Meera Menon TP und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology.
Abstract (Originalsprache)
Optimization of aluminium alginate nanoparticles as adjuvants for therapeutic cancer vaccines against melanoma.
Förderung
- Department of Science and Technology, Ministry of Science and Technology
Zitieren
APA
TP, M. M., Unnikrishnan, A., Sam, R. E., Ashif, M., George, J., KC, B., Sivan, U., Vengellur, A., & Ashokan, A. (2025). Aluminium-complexed alginate nanoparticles as an adjuvant for therapeutic vaccines against melanoma. RSC Pharmaceutics, 2(6), 1593-1602. https://doi.org/10.1039/d5pm00111k
Vancouver
TP MM, Unnikrishnan A, Sam RE, Ashif M, George J, KC B, et al. Aluminium-complexed alginate nanoparticles as an adjuvant for therapeutic vaccines against melanoma. RSC Pharmaceutics. 2025;2(6):1593-1602. doi:10.1039/d5pm00111k
BibTeX
@article{TP2025,
author = {TP, Meera Menon and Unnikrishnan, Anjana and Sam, Reba Elsa and Ashif, Mohammed and George, Jisnet and KC, Bins and Sivan, Unnikrishnan and Vengellur, Ajith and Ashokan, Anusha},
title = {Aluminium-complexed alginate nanoparticles as an adjuvant for therapeutic vaccines against melanoma},
journal = {RSC Pharmaceutics},
year = {2025},
volume = {2},
number = {6},
pages = {1593--1602},
doi = {10.1039/d5pm00111k}
}
EUVIMED